S&P 500   4,237.53 (-1.08%)
DOW   33,742.71 (-0.75%)
QQQ   326.25 (-0.92%)
AAPL   173.28 (-0.50%)
MSFT   288.16 (-0.69%)
META   170.57 (-2.34%)
GOOGL   118.61 (-1.30%)
AMZN   140.15 (-1.51%)
TSLA   894.08 (-1.60%)
NVDA   183.30 (-2.36%)
NIO   19.37 (-2.71%)
BABA   90.89 (+0.17%)
AMD   98.23 (-2.20%)
T   18.44 (+0.05%)
MU   61.61 (-2.18%)
CGC   3.77 (-1.05%)
F   16.12 (-0.19%)
GE   77.98 (-1.55%)
DIS   120.98 (-1.38%)
AMC   18.37 (-4.77%)
PYPL   97.54 (-2.32%)
PFE   48.98 (+0.82%)
NFLX   240.96 (-1.72%)
S&P 500   4,237.53 (-1.08%)
DOW   33,742.71 (-0.75%)
QQQ   326.25 (-0.92%)
AAPL   173.28 (-0.50%)
MSFT   288.16 (-0.69%)
META   170.57 (-2.34%)
GOOGL   118.61 (-1.30%)
AMZN   140.15 (-1.51%)
TSLA   894.08 (-1.60%)
NVDA   183.30 (-2.36%)
NIO   19.37 (-2.71%)
BABA   90.89 (+0.17%)
AMD   98.23 (-2.20%)
T   18.44 (+0.05%)
MU   61.61 (-2.18%)
CGC   3.77 (-1.05%)
F   16.12 (-0.19%)
GE   77.98 (-1.55%)
DIS   120.98 (-1.38%)
AMC   18.37 (-4.77%)
PYPL   97.54 (-2.32%)
PFE   48.98 (+0.82%)
NFLX   240.96 (-1.72%)
S&P 500   4,237.53 (-1.08%)
DOW   33,742.71 (-0.75%)
QQQ   326.25 (-0.92%)
AAPL   173.28 (-0.50%)
MSFT   288.16 (-0.69%)
META   170.57 (-2.34%)
GOOGL   118.61 (-1.30%)
AMZN   140.15 (-1.51%)
TSLA   894.08 (-1.60%)
NVDA   183.30 (-2.36%)
NIO   19.37 (-2.71%)
BABA   90.89 (+0.17%)
AMD   98.23 (-2.20%)
T   18.44 (+0.05%)
MU   61.61 (-2.18%)
CGC   3.77 (-1.05%)
F   16.12 (-0.19%)
GE   77.98 (-1.55%)
DIS   120.98 (-1.38%)
AMC   18.37 (-4.77%)
PYPL   97.54 (-2.32%)
PFE   48.98 (+0.82%)
NFLX   240.96 (-1.72%)
S&P 500   4,237.53 (-1.08%)
DOW   33,742.71 (-0.75%)
QQQ   326.25 (-0.92%)
AAPL   173.28 (-0.50%)
MSFT   288.16 (-0.69%)
META   170.57 (-2.34%)
GOOGL   118.61 (-1.30%)
AMZN   140.15 (-1.51%)
TSLA   894.08 (-1.60%)
NVDA   183.30 (-2.36%)
NIO   19.37 (-2.71%)
BABA   90.89 (+0.17%)
AMD   98.23 (-2.20%)
T   18.44 (+0.05%)
MU   61.61 (-2.18%)
CGC   3.77 (-1.05%)
F   16.12 (-0.19%)
GE   77.98 (-1.55%)
DIS   120.98 (-1.38%)
AMC   18.37 (-4.77%)
PYPL   97.54 (-2.32%)
PFE   48.98 (+0.82%)
NFLX   240.96 (-1.72%)
NASDAQ:AEMD

Aethlon Medical - AEMD Stock Forecast, Price & News

$1.27
-0.09 (-6.62%)
(As of 08/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.22
▼
$1.35
50-Day Range
$0.94
▼
$1.99
52-Week Range
$0.88
▼
$5.99
Volume
996,024 shs
Average Volume
12.41 million shs
Market Capitalization
$21.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

Aethlon Medical MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
215.0% Upside
$4.00 Price Target
Short Interest
Healthy
0.78% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.41mentions of Aethlon Medical in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.68 out of 5 stars

Medical Sector

1007th out of 1,119 stocks

Surgical & Medical Instruments Industry

96th out of 111 stocks

See Top Rated MarketRank™ Stocks Here
AEMD stock logo

About Aethlon Medical (NASDAQ:AEMD) Stock

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Aethlon Medical to a "sell" rating in a research report on Friday, August 12th.

Aethlon Medical Stock Down 6.6 %

Shares of AEMD traded down $0.09 during mid-day trading on Thursday, hitting $1.27. The company had a trading volume of 996,024 shares, compared to its average volume of 1,845,548. Aethlon Medical has a 1-year low of $0.88 and a 1-year high of $5.99. The business's 50-day simple moving average is $1.16 and its 200-day simple moving average is $1.25. The stock has a market cap of $21.13 million, a PE ratio of -1.71 and a beta of 0.77.

Aethlon Medical (NASDAQ:AEMD - Get Rating) last posted its quarterly earnings results on Tuesday, June 28th. The medical equipment provider reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.13). Aethlon Medical had a negative net margin of 3,542.86% and a negative return on equity of 59.57%. The business had revenue of $0.01 million during the quarter, compared to analysts' expectations of $1.02 million. On average, sell-side analysts expect that Aethlon Medical will post 0.56 earnings per share for the current year.

Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

AEMD Stock News Headlines

August 17, 2022 | finance.yahoo.com
AEMD: Positive Results in a Range of Conditions, Including COVID-19 & Monkey Pox
August 15, 2022 | finance.yahoo.com
Aethlon Medical, Inc. (NASDAQ:AEMD) Is About To Turn The Corner
August 19, 2022 | Investing Trends (Ad)
Is the US Military Secretly Under Chinese Control?
Alarmingly, the answer may be "yes". Communist China now controls 80% of the lithium that powers most US military vehicles and equipment. The threat level is so high that the White House recently declared a state of emergency on lithium...
August 15, 2022 | americanbankingnews.com
Aethlon Medical (NASDAQ:AEMD) Rating Increased to Sell at StockNews.com
August 10, 2022 | seekingalpha.com
Aethlon Medical, Inc.'s (AEMD) CEO Chuck Fisher on Q1 2023 Results - Earnings Call Transcript
August 10, 2022 | finance.yahoo.com
Aethlon Medical To Start Lab Studies For Hemopurifier For Monkeypox
August 7, 2022 | americanbankingnews.com
Aethlon Medical (AEMD) to Release Quarterly Earnings on Tuesday
August 3, 2022 | finance.yahoo.com
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022
August 19, 2022 | Investing Trends (Ad)
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War
Right now, China has the US Military in a stranglehold. They hold a monopoly on one of our most CRITICAL defense elements. But thanks to executive orders from both Biden and Trump...
August 3, 2022 | americanbankingnews.com
Stock Traders Purchase Large Volume of Aethlon Medical Call Options (NASDAQ:AEMD)
July 29, 2022 | americanbankingnews.com
Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Expands By 223.0%
July 28, 2022 | finance.yahoo.com
Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants
July 11, 2022 | nasdaq.com
FDA Approves Aethlon Medical's Protocol Amendment For COVID-19 Trial
June 29, 2022 | seekingalpha.com
Aethlon Medical, Inc.'s (AEMD) CEO Chuck Fisher on Q4 2022 Results - Earnings Call Transcript
June 29, 2022 | finance.yahoo.com
AEMD: Positive Results in a Range of Conditions, Including COVID-19 & Monkeypox
June 28, 2022 | seekingalpha.com
Aethlon Medical Q4 2022 Earnings Preview
June 27, 2022 | benzinga.com
Earnings Outlook For Aethlon Medical
June 21, 2022 | finance.yahoo.com
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022
May 24, 2022 | finance.yahoo.com
/C O R R E C T I O N -- Aethlon Medical, Inc./
May 21, 2022 | finance.yahoo.com
Is Aethlon Medical (NASDAQ:AEMD) In A Good Position To Deliver On Growth Plans?
May 9, 2022 | finance.yahoo.com
AEMD: Effectiveness of Hemopurifier on COVID-19 Variants In Vitro Indicates Device’s Potential Range
May 2, 2022 | finance.yahoo.com
Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants
February 15, 2022 | finance.yahoo.com
AEMD: Positive Takeaways from Plan to Expand Clinical Efforts
February 13, 2022 | benzinga.com
Aethlon Medical's Earnings Outlook
February 11, 2022 | seekingalpha.com
Aethlon Medical Q3 2022 Earnings Preview
January 31, 2022 | finance.yahoo.com
Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022
November 30, 2021 | finance.yahoo.com
Here's Why We're Not Too Worried About Aethlon Medical's (NASDAQ:AEMD) Cash Burn Situation
See More Headlines
Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

AEMD Company Calendar

Last Earnings
6/28/2022
Today
8/19/2022
Next Earnings (Estimated)
11/08/2022
Fiscal Year End
3/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AEMD
CUSIP
N/A
CIK
773910
Web
www.aethlonmedical.com
Phone
(858) 459-7800
Fax
N/A
Employees
10
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.00
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+215.0%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.73)
Trailing P/E Ratio
N/A
Forward P/E Ratio
2.27
P/E Growth
N/A
Net Income
$-10,420,000.00
Net Margins
-3,542.86%
Pretax Margin
-6,931.48%
Return on Equity
-59.57%
Return on Assets
-54.53%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.66
Quick Ratio
9.66

Sales & Book Value

Annual Sales
$290,000.00
Price / Sales
72.87
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.90 per share
Price / Book
1.41

Miscellaneous

Outstanding Shares
16,640,000
Free Float
16,106,000
Market Cap
$21.13 million
Optionable
Not Optionable
Beta
0.77

Key Executives

  • Dr. Charles J. Fisher Jr. (Age 75)
    M.D., CEO, Director & Member of Extracorporeal Therapy Advisory Board
    Comp: $509.14k
  • Mr. James B. Frakes M.B.A. (Age 65)
    CFO, Sr. VP of Fin. & Sec.
    Comp: $385k
  • Mr. Steven P. Larosa M.D.
    Chief Medical Officer & Acting Chief Scientific Officer
  • Mr. Guy F. Cipriani BS (Eng.) (Age 52)
    MBA, Sr. VP, Chief Bus. Officer & Director
    Comp: $29.75k
  • Mr. Sunil Sawhney
    Head of Clinical Studies
  • Dr. Richard H. Tullis Ph.D. (Age 77)
    Consultant

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













AEMD Stock - Frequently Asked Questions

What is Aethlon Medical's stock price forecast for 2022?

0 brokerages have issued 12-month price targets for Aethlon Medical's shares. Their AEMD share price forecasts range from $4.00 to $4.00. On average, they expect the company's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 215.0% from the stock's current price.
View analysts price targets for AEMD or view top-rated stocks among Wall Street analysts.

How have AEMD shares performed in 2022?

Aethlon Medical's stock was trading at $1.86 on January 1st, 2022. Since then, AEMD shares have decreased by 31.7% and is now trading at $1.27.
View the best growth stocks for 2022 here.

When is Aethlon Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our AEMD earnings forecast.

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) released its quarterly earnings results on Tuesday, June, 28th. The medical equipment provider reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by $0.13. The medical equipment provider earned $0.01 million during the quarter, compared to the consensus estimate of $1.02 million. Aethlon Medical had a negative net margin of 3,542.86% and a negative trailing twelve-month return on equity of 59.57%.

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), OrganiGram (OGI), AT&T (T) and Aurora Cannabis (ACB).

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

Who are Aethlon Medical's major shareholders?

Aethlon Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Natixis (0.15%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends.

How do I buy shares of Aethlon Medical?

Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $1.27.

How much money does Aethlon Medical make?

Aethlon Medical (NASDAQ:AEMD) has a market capitalization of $21.13 million and generates $290,000.00 in revenue each year. The medical equipment provider earns $-10,420,000.00 in net income (profit) each year or ($0.73) on an earnings per share basis.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The official website for the company is www.aethlonmedical.com. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at susan@sanoonan.com.

This page (NASDAQ:AEMD) was last updated on 8/19/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.